Member Info for Num4

No need to delay it for that though really, just write about what they know at the present time and then drop another RNS for the CHK1 update..Which is what they should be doing anyway.

Going back to the beginning of time Sar have never missed a Feb interim update. What would drive a delay? We can only speculate but something must be holding back the research update. All for good reasons I'm sure.

What have you done to the board....

Except they have brought forward the release of data at a conference to H2. Sareums next milestone will not be far off.

Webcast link to the presentation: https://www.veracast.com/webcasts/bio/ceoinvestor2018/82115265448.cfm

https://ovariancancernewstoday.com/2018/02/09/trial-shows-prexasertib-shrinks-tumors-in-a-third-of-ovarian-cancer-patients/ More target validation and if Eli are excited about them results then our inhibitor which is more selective against CHK1 will deliver better results as the research suggests the side effects are caused by inhibiting CHK2 during the process. So the more selective you can be to CHK1 the better, i think i read ours is X1325 somewhere...

Plenty buying and no movement. MM's going to get a shock when this pops.

Someone went wild from 3pm onwards till close... Not believing that is different people buying due to lack of interest of late.

Didn't know that companies exist who you can sell future royalties too... https://www.medius-associates.com/wp-content/uploads/2012/06/January-2018-Deal-Watch.pdf See the last pages, interesting and gives us another potential source of income instead of the dreaded placings. Got to be something worth looking into I think.

Glad I only had a small holding here. First time I've had to write off a share, hopefully the last!

Some patent news today and more news on or before 18th Feb. Worth taking a position with as gains could be in the hundreds soon. IMO